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ROBERT L. FELDMAN, MD, FACC, JAMES A. HILL, MD, FACC, C. RICHARD CONTI, MD, FACC, 
CARL J. PEPINE, MD, FACC 
Gainesville, Florida 
The mechanisms responsible for the beneficial effects of 
calcium channel antagonists in patients with effort an-
gina were investigated by studying the coronary hemo-
dynamic responses of the anterior left ventricular region 
before and after administration of nifedipine in 13 pa-
tients whose left anterior descending coronary artery 
was filled by flow from collateral vessels. Nifedipine was 
given bucally in a dose (10 or 20 mg) that decreased 
aortic pressure 5 mm Hg or more. Nifedipine increased 
collateral flow (regional thermodilution) in only three 
patients (p = NS), but consistently decreased coronary 
resistance in the left ventricular anterior region (p < 
0.05). Ahtei-ior region myocardial oxygen consumption 
did not change after nifedipine administration. 
Lactate metabolism was evaluated in eight patients: 
values were abnormal in four patients before nifedipine; 
The mechanism by which calcium channel antagonists pre-
vent or alleviate stress-induced angina in many patients re-
mains unclear. Animal studies (1-5) have shown that drugs 
of this class decrease afterload and myocardial contractility 
(1-5). Coronary effects include dilation of epicardial coro-
nary arteries, increases in coronary blood flow to normally 
perfused regions and a variable effect on flow to regions 
where it is initially decreased (3-5). Studies of patients with 
ischemic heart disease have shown that calcium channel 
antagonists decrease indexes of myocardial oxygen demand 
for a given level of exercise stress and, in some instances, 
increase regional coronary flow (6-16). In patients with 
coronary spasm, calcium channel antagonists prevent epi-
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after nifedipine, values remained abnormal in three of 
these patients and became abnormal in one other. Dur-
ing atrial pacing stress, angina occurred in all patients 
before nifedipine and at the same or lower heart rate in 
nine patients after nifedipine. After nifedipine admin-
istered at the same rate that induced angina during the 
control period, collateral flow and myocardial oxygen 
consumption were usually lower (both p < 0.05), but 
anterior region coronary resistance was unchanged com-
pared with control values. Lactate metabolism was not 
usually improved. Thus, although nifedipine maintained 
collateral flow while aortic pressure decreased, no con-
sistent beneficial effect on pacing-induced angina was 
seen. 
(J Am Coil CardioI1985;5:318-25) 
sodes of spontaneously occurring ischemia by preventing 
increased large vessel coronary tone (16, 17). Coronary spasm, 
however, is not thought to be the usual mechanism that 
precipitates myocardial ischemia in most patients who have 
effort-induced angina without rest angina (18,19). 
The purpose of this study was to evaluate the coronary 
hemodynamic effects of the calcium channel antagonist ni-
fedipine in patients with effort angina and collateral filling 
of the anterior descending branch of the left coronary artery. 
Coronary hemodynamic and metabolic responses in the an-
terior left ventricular region were measured at rest and dur-
ing tachycardia stress before and after nifedipine. 
Methods 
Patients. Thirteen men (average age 56 years, range 36 
to 71) were the subjects of this investigation (Table I). Each 
patient had exercise-induced angina. The proximal portion 
of the anterior descending branch of the left coronary artery 
was totally occluded in II patients and subtotally occluded 
in 2 (Cases II and 13). In each of these patients, the anterior 
descending and major diagonal vessels were filled by col-
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Table 1. Summary of Pertinent Clinical and Angiographic Findings in 13 Patients 
Coronary 
Collateral Left Ventricular 
Propranolol 
Angiogram 
Filling Angiogram 
Age Dose 
(% diameter reduction) 
to 
Case (yr) (mg) LAD LCx RCA LAD EF(%) Wall Motion 
36 0 100 20 20 Good 60 Ant and inf hypokinesia 
2 61 30 100 60 30 Good 57 Ant hypokinesia 
3 54 320 100 30 0 Fair 40 Ant hypokinesia and 
ant akinesia 
4 61 0 100 0 90 Good 25 Ant hypokinesia and 
ant akinesia 
5 56 100 100 60 60 Poor 42 Ant hypokinesia 
6 58 160 100 0 80 Fair 55 Ant hypokinesia 
7 47 120 100 50 100 Good 55 Ant hypokinesia 
8 71 40 100 50 50 Good 47 Ant hypokinesia 
9 48 320 toO 100 100 Good 59 Ant and inf hypokinesia 
\0 66 120 100 50 30 Poor 45 Ant akinesia 
II 54 320 99 30 0 Fair 62 Normal 
12 59 80 100 0 0 Good 50 Ant hypokinesia 
13 62 80 99 0 0 Good 55 Ant hypokinesia 
Ant = anterior; EF = ejection fraction; inf = inferior; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; 
RCA = right coronary artery. 
lateral circulation. No patient had rest angina, ST segment 
elevation or other findings suggesting coronary spasm, myo-
cardial infarction within 2 months of study, valvular heart 
disease or symptoms of heart failure. In all patients, nitrates 
were withheld for at least 8 hours before study. No patient 
was receiving a calcium channel antagonist. Eleven of the 
13 patients were receiving propranolol (30 to 320 mg/day), 
which was continued uninterrupted before catheterization. 
This study was approved on February 23, 1982, by appro-
priate institutional committees for the protection of human 
subjects, and each patient gave written informed consent. 
Cardiac catheterization procedures. Catheterization 
was performed after the patients had fasted for 8 to 12 hours. 
They were given 25 mg of oral diphenhydramine hydro-
chloride (Benadryl) I to 2 hours before study. Arterial cath-
eterization was performed using the Sones technique. An 
8F Sones catheter was positioned from the right brachial 
artery in the aorta and advanced to the left ventricle to record 
end-diastolic pressure. The catheter was then withdrawn to 
the aorta and the patient positioned in a left anterior oblique 
position with various degrees of cranial angulation. A left 
coronary artery angiogram was performed to evaluate the 
left main coronary artery and the proximal anterior descend-
ing and circumflex branches. Patients with total or subtotal 
occlusion of the anterior descending branch who had pre-
viously volunteered were then continued on the study. In 
other patients, the routine catheterization procedure was 
continued. 
Venous catheterization was performed using a multi-
thermistor catheter advanced from a right antecubital vein 
to the coronary sinus. Our use of this catheter to measure 
regional left ventricular blood flow has been described pre-
viously (20-23). The distal external thermistor was ad-
vanced to the great cardiac vein and the proximal external 
thermistor was positioned in the coronary sinus between the 
ostium and the termination of the middle cardiac vein. A 
coronary venous angiogram was recorded on a video disk 
recorder using 2 or 3 ml of Renografin-76. This image was 
used to aid proper positioning of the clttheter in the sinus. 
Location of the catheter was frequently checked by referring 
to these recordings and fluoroscopic reference to skeletal 
landmarks. Three electrocardiographic leads (I, II and V 5) 
were recorded and continuously monitored. During each 
measurement period, all other standard limb leads and lead 
V 5 were also recorded. This study was divided into control 
and nifedipine periods (Table 2). 
Control period. Rest. Approximately 10 minutes after 
the last injection of contrast mec\iuOl, recordings of the 
electrocardiogram and aortic and left ventricular pressures 
and great cardiac vein and indicator temperature signals 
were made. No patient had clinical symptoms or electro-
cardiographic signs to suggest transient myocardial ischemia 
during this interval or for several hours before these re-
cordings. Arterial and great cardiac vein blood samples were 
obtained. Duplicate measurements of oxygen saturation (12 
patients) and lactate content (8 patients) were made by tech-
niques described previously (21 ,23). After these recordings, 
pressures were monitored continuously. 
Pacing. Atrial pacing was initiated at a rate 10 beats 
higher than the intrinsic rate. Heart rate was then increased 
\0 beats/min until angina occurred. During angina, record-
ings of the electrocardiogram, pressures and great cardiac 
vein and indicator signals were made and blood samples 
obtained. Pacing was then terminated. 
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Table 2. Summary of Left Ventricular and Systemic Hemodynamic Responses to Nifedipine 
Control Period Nifedipine Period 
C, Pc C2 N, PN N2 
Heart rate (beats/min) 65 ± II 113 ± 14 64 ± II 70 ± 10 112 ± 14 69 ± 12 
Mean aortic pressure (mm Hg) 110 ± 14 120 ± 17 III ± 13 99 ± 9 103 ± 7 94 ± 10 
Len ventricular end-diastolic pressure (mm Hg) 20 ± 6 17 ± 8 21 ± 6 19 ± 6 14 ± 7 17 ± 6 
Rate-pressure product x 10- 2 (mm Hg· beats/min) 99 ± 24 169 ± 28 97 ± 22 92 ± 19 142 ± 18 86 ± 20 
Data are reported as mean ± standard deviation. C" C2 = first and second control rest periods, respectively; N" N2 = first and second nifedipine 
rest periods, respectively; Pc, PN = pacing before and after nifedipine, respectively. 
Rest, At least 5 minutes after pacing was terminated, 
after angina subsided and after ST segment and any hemo-
dynamic changes returned to prepacing values, recor.dings 
of the electrocardiogram, pressures and great cardiac vein 
and indicator signals were repeated, 
Nifedipine period. Rest, The patient was given 10 mg 
of nifedipine buccally and electrocardiographic and aortic 
pressure signals were monitored for 15 minutes. If the sys-
tolic aortic pressure remained greater than 90 mm Hg and 
had not decreased 5 mm Hg or more, an additional 10 mg 
of nifedipine was administered. Fifteen minutes after the 
last nifedipine dose, recordings of the electrocardiogram, 
pressures and great cardiac vein and indicator signals were 
made and blood samples obtained, 
Pacing, Heart rate was again increased in exactly the 
same manner as during the control period until angina or 
the same heart rate was reached, Recordings of the electro-
cardiogram, pressures and great cardiac vein and indicator 
signals were made and blood samples were obtained, If 
angina had not occurred, pacing was continued and heart 
rate increased in increments of 10 beats/min until angina 
occurred. 
Rest. After symptoms subsided and ST segment and 
hemodynamic changes returned toward prepacing values, 
recordings of the electrocardiogram, pressures and great 
cardiac vein and indicator signals were repeated in eigqt 
patients, Selective coronary and left ventricular angiography 
were then completed using standard techniques. 
Data analysis. Great cardiac vein blood flow was cql-
culated from simultaneously recorded temperature sign~ls 
as described elsewhere (20-23) and was used as an index 
of flow in the anterior region of the left ventricle, Phasic 
and mean aortic pressures and left ventricular end-diastolic 
pressure were determined by averaging measurements ob-
tained from at least 10 consecutive beats. Heart rate was 
calculated from the electrocardiogram, Arterial and great 
cardiac vein oxygen content was calculated as the product 
of oxygen saturation, hemoglobin concentration values and 
1.34 (a conversion factor to get from percent saturation to 
oxygen content), Regional oxygen consumption (mllmin) 
was determined as the product of the difference between 
arterial and regional coronary venous oxygen content and 
regional flow, The percent of regional lactate extraction was 
calculated as the difference between arterial lactate and an-
terior region coronary venous lactate divided by arterial 
lactate times 100%, A value of 10% or more was considered 
norma), An index of anterior region coronary resistance was 
calculated from the quotient of mean aortic pressure and 
anterior region flow. To relate myocardial oxygen demand 
to anterior region flow, we calculated an index as the quo-
tient of rate-pressure product (heart rate X systolic aortic 
pressure) and great cardiac vein flow, This value was mul-
tiplied by 10- 2 to make it numerically similar to resistance 
values, 
Coronary angiograms were analyzed as described pre-
viously to determine the percent of diameter reduction of 
each stenosis (20-23), Collateral filling of the anterior de-
scending branch was judged angiographically. Good filling 
was defined as opacification of the collaterally filled anterior 
descending branch equal to that of vessels directly filled, 
Poor filling was defined as just detectable opacification, Fair 
filling was defined as between good and poor. 
Statistical analysis. Mean values ± I standard devia-
tion were determined for each variable during each period. 
An analysis of variance for repeated measures was per-
formed for each variable, If significant, the analysis of var-
iance was followed by an appropriate multiple comparison 
procedure. Lactate extraction data were grouped as either 
normal or abnormal and compared by using the Fisher exact 
probability test. A probability (p) value of 0,05 or less was 
considered significant. 
Results 
Data concerning pertinent clinical and coronary and left 
ventricular angiographic findings are summarized in Table 
I, No adverse effects were detected after nifedipine admin-
istration or from the catheterization. 
Angina and ST depression. No clinical or electrocar-
diographic evidence for transient myocardial ischemia was 
present during any of the four rest sequences before or after 
nifedipine, Angina and ST segment depression of I mm or 
more occurred in each patient during atrial pacing in the 
control period. After nifedipine, angina and ST segment 
depression of similar magnitude occurred in 8 of the 13 
patients at the same rate as during control pacing, Patient 
l'
2
I to
to 2
: 2
.
.
.
.
,
.
al
.
.
.
.
,
x
.
·
.
.
.
.
lACC Vol. 5, No, 2 
February 1985:318-25 
6 
( 
y 
F 
75 
50 
35 
_Ijmin 
Ii 
( 
y 
F 
75 
20~~~~~~~~1 
o 
IImHg 
2~1..A-.~ 
V51~~ 
L_ ~~.~~9 -----L 
50 
35 
mlj_in 
i 
2:(}t--Ti-. I t-t- ~-tr-.,--
oj V 
.. mHg 
PACE 
CONTROL 
~
AFTER NFEDIPINE 
.~~ 
I 59 I 
1\ 1\ L1JL 
I 
I 
~----1f---+----+ 
, • j~. (~~-ti,,,, -----+ 
13 had angina at a lower heart rate (120 versus 110 beats/min, 
control period versus nifedipine period) and Patients I, 3, 
5 and 6 had angina only at a higher heart rate (130 versus 
140, 110 versus 120, 120 versus 130 and 90 versus 120 
beats/min, respectively). 
Systemic and left ventricular hemodynamic findings 
(Table 2). A representative example of the pressure and 
flow signals is presented in Figure I. Heart rate and pres~ 
sures were similar before and after pacing stress in both 
control and nifedipine rest periods; therefore, all subsequent 
comparisons between periods were made using only values 
before and during pacing. After nifedipine at rest, heart rate 
increased slightly (mean 8%, p < 0.05), mean aortic pres~ 
sure decreased 10% (p < 0.05), left ventricular end~diastolic 
pressure was unchanged and the rate~pressure product de~ 
creased 7% (p < 0.05). During control pacing the heart rate 
that induced angina ranged from 90 to 140 beats/min. Mean 
aortic pressure increased and left ventricular end~diastolic 
pressure decreased during pacing in the control and nifed~ 
ipine periods compared with values before and after pacing 
(all p < 0.05). After nifedipine, mean aortic pressure was 
14% lower (p < 0.05), left ventricular end~diastolic pressure 
was unchanged and the rate~pressure product decreased 16% 
(p < 0.05) compared with control pacing values. 
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Figure 1. Patient 12. Representative ex-
ample of electrocardiogram, left ventric-
ular aortic pressures and great cardiac vein 
blood flow (GCYF) signals before, during 
and after pacing stress during the control 
(top) and nifedipine (bottom) periods. At 
rest (left and right panels), nifedipine 
decreased aortic pressure and maintained 
great cardiac vein blood flow. During 
pacing (middle panel), angina occurred 
at the same rate before and after nifedi-
pine; aortic pressure and great cardiac vein 
blood flow were lower than during the 
control period. 
Anterior region coronary hemodynamic responses 
(Table 3 and Fig. 2). Great cardiac vein flow was usually 
unchanged when comparing values before and after pacing 
during the control and nifedipine periods. All subsequent 
comparisons were made before and during pacing in the 
control and nifedipine periods. Although mean great cardiac 
vein flow was not significantly changed after nifedipine, it 
clearly appeared to increase 5 ml or more over that in the 
control period in four patients (Cases 2, 6, 7 and 13) despite 
a decrease in aortic pressure. In two patients (Cases 3 and 
II), nifedipine seemed to decrease great cardiac vein flow. 
Pacing increased great cardiac vein flow during both periods 
(both p < 0.05 compared with control and nifedipine rest 
periods before pacing, respectively). Great cardiac vein flow 
was higher during control pacing than during pacing after 
nifedipine in 9 of 13 patients (p < 0.05). 
Anterior region coronary resistance was often slightly 
lower after pacing as compared with resistance before pacing 
during both periods. After nifedipine and before pacing, 
anterior region resistance was 12% lower than during the 
control rest period (p < 0.05). In 8 of the 13 patients, 
resistance values after nifedipine were lower than values 
during both control periods. During pacing, resistance de-
creased in 12 of 13 patients in both periods (both p < 0.05 
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compared with control and nifedipine rest periods). In con-
trast with resistance values at rest, values during pacing in 
both periods were similar. 
The ratio of rate-pressure product to great cardiac vein 
flow was usually unchanged ( ± 10%) before and after pac-
ing during the control and nifedipine periods. After nifed-
ipine, values were similar to those during the control period 
(p = NS). During pacing this demand/supply ratio was 
either similar to or slightly greater than respective rest values 
(both p < 0.05 compared with control and nifedipine rest 
periods). Pacing values were similar during control and 
nifedipine periods. A slight increase in a demand/supply 
ratio was expected during pacing because angina was present 
in all patients during control pacing and in 10 during pacing 
after nifedipine. Even in the three patients without angina 
during pacing after nifedipine, this demand/supply ratio was 
slightly increased during pacing after nifedipine. 
Nifedipine increased great cardiac vein oxygen satura-
tion (33 ± 5 to 36 ± 6%; p < 0.05, control period versus 
nifedipine period, respectively) and decreased anterior re-
gion myocardial oxygen extraction (12.1 ± 1.4 to 10.8 ± 
1.6 ml oxygen; p < 0.05). Anterior region myocardial ox-
ygen consumption did not significantly change. As ex-
pected, pacing increased oxygen consumption during both 
periods (both p < 0.05). This value was slightly lower in 
9 of the 11 patients during pacing in the nifedipine period 
(p < 0.05). During pacing, great cardiac vein oxygen sat-
uration (38 ± 10 to 39 ± 8%) and anterior region myo-
cardial oxygen extraction (11.1 ± 2.0 to 10.8 ± 1.7 ml 
oxygen) were similar during both periods. 
Anterior region lactate metabolism was abnormal in four 
of the eight patients in whom it was measured. After ni-
fedipine, it remained abnormal in three of these patients and 
became abnormal in one other. During control pacing, lac-
tate production occurred in six of eight patients. During 
pacing after nifedipine, lactate metabolism was abnormal 
in five of seven patients in whom it was measured, and 
lactate production occurred in four. 
Discussion 
Hemodynamic and metabolic effects of nifedipine. 
This study evaluated systemic and coronary hemodynamic 
effects of nifedipine in patients whose anterior left ventric-
ular region was perfused by collateral flow. At rest, nifed-
ipine decreased aortic pressure, which was accompanied by 
a small reflex-mediated increase in heart rate. Left ventric-
ular filling pressure did not usually change. During nifed-
ipine-induced coronary vasodilation, anterior region flow 
and oxygen consumption were preserved. However, lactate 
metabolism did not appear different during both periods. 
Despite the ability of nifedipine to preserve anterior region 
collateral flow while decreasing aortic pressure at rest, there 
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150 GREAT CARDIAC VEIN FLOW (mllmin) 12 ANTERIOR REGION OXYGEN CONSUMPTION 
(mI02,min) 
lOa 
:.:i.·.:,:::.i:~.;:~.i.;.~.;.: . ~.;.: t?n 50~--~~L-~L-~--~~--~~ 
-
2.5 ANTERIOR REGION CORONARY RESISTANCE 2.5 
(mm Hg/mllmin) 
MYOCARDIAL OXGEN DEMAND TO SUPPLY INDEX 
(mm Hg x beat/min) 
Figure 2. Summary of mean values for 
great cardiac vein blood flow (top left), 
anterior region oxygen consumption (top 
right) and resistance (bottom left) and 
the coronary demand to supply index 
(bottom right), which is the quotient of 
rate-pressure product and great cardiac vein 
flow. Data are given for the initial rest 
period and during pacing for the control 
and nifedipine periods. 2.0 
2.0 
CONTROL 
rest pace rest pace rest pace 
was little clinical, coronary hemodynamic or metabolic evi-
dence of improvement during atrial pacing (Fig. I and 2). 
During atrial pacing in the nifedipine period, when aortic 
pressure was lower than during the control period, angina 
was reproduced at the same or lower heart rate in 9 of the 
13 patients. Thus, the rate-pressure product at which angina 
occurred was usually lower after nifedipine. Anteri('r region 
coronary flow and oxygen consumption were al':o lower 
during pacing after nifedipine. Lactate metabolism contin-
ued to be abnormal in some patients, even at a lower value 
of myocardial oxygen consumption. The potential mecha-
nisms for myocardial ischemia after nifedipine at a lower 
rate-pressure product include decreased coronary perfusion 
pressure and a shortened diastolic filling period during pac-
ing tachycardia as compared with that during rest. Addi-
tionally, nifedipine-induced arteriolar dilation may have led 
to an early exhaustion of autoregulatory reserve and diver-
sion of flow to nonischemic myocardium. 
Comparison of effects of nifedipine and nitro-
glycerin. These data suggest that in patients with occlusion 
of the left anterior descending coronary artery. nifedipine 
may maintain collateral flow despite a decrease in aortic 
pressure at rest; however. no beneficial action was apparent 
during pacing stress. Changes in coronary hemodynamics 
after nifedipine at rest were very similar to those we pre-
viously measured after nitroglycerin administration in a sim-
ilar group of patients whose anterior descending coronary 
artery filled by collateral circulation (23), After both drugs 
were administered. aortic pressure decreased but anterior 
region coronary flow and oxygen consumption were pre-
served. The effects of nitroglycerin on clinical and coronary 
hemodynamics during atrial pacing cannot be compared be-
cause a similar group of patients has not been evaluated in 
this manner. 
Comparison with similar studies of calcium channel 
antagonists. Although other investigators have evaluated 
rest pace 
coronary hemodynamic effects of nifedipine and other cal-
cium channel antagonists in patients, there were important 
differences between this study and previous ones. This study 
was limited to a precisely defined group of patients; all 
patients derived a major portion of anterior region perfusion 
by collateral flow. Previous coronary hemodynamic eval-
uations of nifedipine (9-15) have included patients with 
various degrees of coronary stenoses. Additionally, previous 
studies (9, 11,13.15) often evaluated only global coronary 
hemodynamic responses. Some studies (2,15) evaluated 
coronary hemodynamic responses only while patients were 
at rest. Because of similarities between the study of Specchia 
et al. (10) and ours, further discussion of their findings 
seems appropriate. They evaluated anterior region coronary 
hemodynamics before and after nifedipine at rest and during 
exercise in patients with anterior descending artery stenosis. 
Nifedipine increased exercise capacity in half the patients. 
An increased exercise capacity seemed secondary to in-
creased anterior region coronary flow. Three of their patients 
had anterior descending coronary artery occlusion and so 
are comparable with our patients. None of these three pa-
tients increased their exercise capacity or improved coronary 
hemodynamics after receiving nifedipine. 
Speculation on the mechanism of the action of nifed-
ipine. When considering our observations and those of other 
investigators, it is appropriate to speCUlate on mechanisms 
leading to the beneficial action of nifedipine in patients with 
exertional angina. Although, on the basis of our observa-
tions, nifedipine does not usually improve collateral per-
fusion, it could still improve perfusion to left ventricular 
regions not der'ndent on collateral flow (9.\0,12). Nifed-
ipine also mayvork predominantly through its potent sys-
temic effects, which lead to decreased myocardial oxygen 
demand (24.25). These effects might be more prominent in 
the standing position or during exercise and more difficult 
to appreciate in supine patients undergoing pacing stress 
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tests. For example, nifedipine may prevent the usual cardiac 
output and systemic pressure increases observed during ex-
ercise stress; these effects would be absent or less prominent 
during pacing stress. 
Limitations of the study. Several limitations of the study 
require discussion. I) Eleven of the 13 patients evaluated 
in this study were taking propranolol. Thus, the observed 
effects in the control and nifedipine periods were those of 
propranolol alone and propranolol plus nifedipine, respec-
tively. Nifedipine might have improved collateral flow and 
regional metabolism if these patients had not been receiving 
a beta-receptor blocking agent. However, in other studies 
(26) the beneficial effect of nifedipine was prominent when 
given with propranolol. 2) Anterior region wall motion was 
abnormal in most patients. Histologic examination was not 
available in any patient, but various degrees of fibrotic, 
ischemic and normal myocardium presumably existed. 
3) Epicardial coronary arteries supplying collateral filling to 
the anterior descending branch were usually stenosed to 
various degrees. Beneficial effects might have been ob-
served if these adjacent vessels were not stenosed. 4) Ni-
fedipine was administered in relatively low doses designed 
to induce a slight change in mean aortic pressure. A larger 
dose of nifedipine might have increased collateral flow and 
improved regional metabolism in more patients at rest or 
during pacing. 5) For great cardiac vein effluent to best 
represent anterior region collateral flow and its venous drain-
age, only patients with total or subtotal occlusion of the 
anterior descending branch proximal to major septal or di-
agonal branches were evaluated. Patients with this coronary 
anatomy are uncommon, and thus only 13 patients were 
studied. It is possible that if the collaterally perfused left 
ventricular region was smaller or if the anterior descending 
artery was less narrowed, nifedipine might have produced 
beneficial effects. 6) Great cardiac vein effluent contains 
venous drainage of the anterior left ventricular wall. Thus, 
in addition to anterior descending branch effluent, inter-
mediate and diagonal branch and perhaps high circumflex 
branch venous drainage may contribute a variable amount 
to great cardiac vein effluent. Thus, our measurements of 
metabolism can be considered only as estimates of collateral 
perfusion. 
Conclusion. In patients whose anterior descending coro-
nary artery was filled by collateral circulation, nifedipine 
given in doses that induced a slight decrease in aortic pres-
sure maintained but did not consistently increase great car-
diac vein flow and had no major effects on myocardial 
oxygen consumption or lactate metabolism. During atrial 
pacing, nifedipine usually did not prevent angina, increase 
collateral flow or improve anterior region oxygen con-
sumption or lactate metabolism. These data suggest that the 
beneficial action of nifedipine in patients with effort angina 
is not due to an increase in myocardial perfusion to regions 
dependent on collateral flow. 
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